The clonal and mutational evolution spectrum of primary triple-negative breast cancersSohrab P. Shah, J Costello, Andrew Roth et al.|Nature|2012Cited by 2k
Current Landscape of Immunotherapy in Breast CancerSylvia Adams, Elizabeth A. Mittendorf, Margaret E. Gatti‐Mays et al.|JAMA Oncology|2019Cited by 409
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term OutcomesKristine Broglio, Donald A. Berry, Melanie Quintana et al.|JAMA Oncology|2016Cited by 375
Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast CancersStephen Chia, Karen A. Gelmon|Journal of Clinical Oncology|2008Cited by 299
Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the BreastCharles C. Wykoff, Adrian L. Harris, Nigel Beasley et al.|American Journal Of Pathology|2001Cited by 250